MiRNA Polymorphisms and Cancer Prognosis: A Systematic Review and Meta-Analysis

Overview

Journal Front Oncol

Specialty Oncology

Date 2019 Jan 9

PMID 30619739

Citations 24

Authors

Han-Xi Ding

Zhi Lv

Yuan Yuan

Qian Xu

Affiliations

Soon will be listed here.

Abstract

Accumulating studies have focused on the relationship between miRNAs polymorphisms and cancer prognosis. However, the results are conflicting and unconvincing. This systematic review and meta-analysis was conducted to explore the relationship between miRNAs polymorphisms and cancer prognosis, aiming to seek for markers with cancer prognostic function. Hazard ratio of overall survival, disease-free survival (DFS) and recurrence-free survival were calculated to evaluate the association between miRNAs polymorphisms and cancer prognosis by using Stata software 11.0. We systematically reviewed the association of 17 miRNAs SNPs with cancer prognosis including 24,721 samples. It was shown that 6 miRNAs SNPs (miR-608 rs4919510, miR-492 rs2289030, miR-378 rs1076064, miR-499 rs4919510, miR-149 rs2292832, miR-196a2 rs11614913) were associated with better cancer overall survival (OS) while let-7i rs10877887 was associated with poor OS; the homozygous and heterozygote genotype of miR-423 were related to poor cancer relapse-free survival (RFS) when compared with the wild genotype; miR-146 rs2910164 was linked to favorable cancer DFS while miR-196a2 rs11614913 was associated with poor DFS. In summary, let-7i rs10877887, miR-608 rs4919510, miR-492 rs2289030, miR-378 rs1076064, miR-423 rs6505162, miR-499 rs4919510, miR-149 rs2292832, miR-146 rs2910164, and miR-196a2 rs11614913 might serve as potential biomarkers for cancer prognosis.

Citing Articles

Knowledge mapping of exosomes in prostate cancer from 2003 to 2022: a bibliometric analysis.

Li Y, Ma L, Chen H, Jin Z, Yang W, Qiao Y Discov Oncol. 2024; 15(1):307.

PMID: 39048891 PMC: 11269540. DOI: 10.1007/s12672-024-01183-x.

The regulation of microRNAs on chemoresistance in triple-negative breast cancer: a recent update.

Yan L, Lau A, Xu Y Epigenomics. 2024; .

PMID: 38639712 PMC: 11160456. DOI: 10.2217/epi-2023-0430.

Assessment of the relationship between miR-499C/T (rs3746444) polymorphism and lung carcinoma in Iranian population; a case-control study.

Torabi M, Khafaei M, Jahanbin B, Sadeghi M Afr Health Sci. 2024; 23(3):301-307.

PMID: 38357128 PMC: 10862644. DOI: 10.4314/ahs.v23i3.36.

The role of miR-223 in breast cancer; an integrated analysis.

Sahin Y, Altan Z, Karabulut A, Saadat K, Arslan A Mol Biol Rep. 2023; 50(12):10179-10188.

PMID: 37924447 DOI: 10.1007/s11033-023-08850-2.

Dual mechanism of Let-7i in tumor progression.

Zhou J, Xiang H, Cao Z Front Oncol. 2023; 13:1253191.

PMID: 37829341 PMC: 10565035. DOI: 10.3389/fonc.2023.1253191.

References

Sterne J, Egger M . Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001; 54(10):1046-55. DOI: 10.1016/s0895-4356(01)00377-8. View

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J . The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003; 425(6956):415-9. DOI: 10.1038/nature01957. View

Tierney J, Stewart L, Ghersi D, Burdett S, Sydes M . Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007; 8:16. PMC: 1920534. DOI: 10.1186/1745-6215-8-16. View

Lee D, Deng Z, Wang C, Yang B . MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci U S A. 2007; 104(51):20350-5. PMC: 2154434. DOI: 10.1073/pnas.0706901104. View

Jazdzewski K, Murray E, Franssila K, Jarzab B, Schoenberg D, de la Chapelle A . Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2008; 105(20):7269-74. PMC: 2438239. DOI: 10.1073/pnas.0802682105. View

Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L . Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest. 2008; 118(7):2600-8. PMC: 2402113. DOI: 10.1172/JCI34934. View

Slack F, Weidhaas J . MicroRNA in cancer prognosis. N Engl J Med. 2008; 359(25):2720-2. PMC: 10035200. DOI: 10.1056/NEJMe0808667. View

Spizzo R, Nicoloso M, Croce C, Calin G . SnapShot: MicroRNAs in Cancer. Cell. 2009; 137(3):586-586.e1. DOI: 10.1016/j.cell.2009.04.040. View

10.

Lee H, Kim J, Chae Y, Sohn S, Kang B, Moon J . Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer. J Cancer Res Clin Oncol. 2010; 136(7):1073-8. DOI: 10.1007/s00432-009-0754-6. View

11.

Mudduluru G, Vajkoczy P, Allgayer H . Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer. Mol Cancer Res. 2010; 8(2):159-69. DOI: 10.1158/1541-7786.MCR-09-0326. View

12.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010; 8(5):336-41. DOI: 10.1016/j.ijsu.2010.02.007. View

13.

Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S . MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet. 2010; 6(3):e1000879. PMC: 2837402. DOI: 10.1371/journal.pgen.1000879. View

14.

Braig S, Mueller D, Rothhammer T, Bosserhoff A . MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma. Cell Mol Life Sci. 2010; 67(20):3535-48. PMC: 11115699. DOI: 10.1007/s00018-010-0394-7. View

15.

Ryan B, Robles A, Harris C . Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010; 10(6):389-402. PMC: 2950312. DOI: 10.1038/nrc2867. View

16.

Christensen B, Avissar-Whiting M, Ouellet L, Butler R, Nelson H, McClean M . Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res. 2010; 16(14):3713-20. PMC: 2914465. DOI: 10.1158/1078-0432.CCR-10-0657. View

17.

Lin R, Lin Y, Yu A . miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells. Mol Carcinog. 2010; 49(8):719-27. DOI: 10.1002/mc.20647. View

18.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

19.

Lin J, Horikawa Y, Tamboli P, Clague J, Wood C, Wu X . Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis. 2010; 31(10):1805-12. PMC: 2981457. DOI: 10.1093/carcin/bgq168. View

20.

Grant D, LONG W, Moffat C, Williamson F . Infrared spectroscopy as a method for investigating the conformations of iduronate saccharide residues in glycosaminoglycans. Biochem Soc Trans. 1990; 18(6):1277-9. DOI: 10.1042/bst0181277a. View